ARTV vs. CGON
ARTV (Artiva Biotherapeutics, Inc) and CGON (CG Oncology, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past year, ARTV returned 504.94% vs 156.16% for CGON. At a 0.34 correlation, their price movements are largely independent.
Performance
ARTV vs. CGON - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARTV achieves a 128.44% return, which is significantly higher than CGON's 58.31% return.
ARTV
- 1D
- 4.70%
- 1M
- 24.52%
- YTD
- 128.44%
- 6M
- 129.51%
- 1Y
- 504.94%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CGON
- 1D
- -0.78%
- 1M
- 2.30%
- YTD
- 58.31%
- 6M
- 64.12%
- 1Y
- 156.16%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ARTV vs. CGON - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ARTV Artiva Biotherapeutics, Inc | 128.44% | -57.44% | -37.00% |
CGON CG Oncology, Inc | 58.31% | 44.77% | -21.90% |
Correlation
The correlation between ARTV and CGON is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Jul 19, 2024 | 0.34 |
Fundamentals
ARTV:
$241.85M
CGON:
$5.56B
ARTV:
-$3.55
CGON:
-$1.61
ARTV:
2.75
CGON:
5.09
ARTV:
$0.00
CGON:
$5.07M
ARTV:
$0.00
CGON:
-$2.54M
ARTV:
-$90.10M
CGON:
-$191.51M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARTV vs. CGON — Risk / Return Rank
ARTV
CGON
ARTV vs. CGON - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Artiva Biotherapeutics, Inc (ARTV) and CG Oncology, Inc (CGON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARTV | CGON | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.02 | ||
| Sortino ratioReturn per unit of downside risk | +0.55 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 1.41 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 10.35 | 5.73 | +4.62 |
| Martin ratioReturn relative to average drawdown | 18.64 | 17.66 | +0.98 |
Loading charts...
Drawdowns
ARTV vs. CGON - Drawdown Comparison
The maximum ARTV drawdown since its inception was -90.81%, which is greater than CGON's maximum drawdown of -67.47%. Use the drawdown chart below to compare losses from any high point for ARTV and CGON.
Loading charts...
Drawdown Indicators
| ARTV | CGON | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.81% | -67.47% | -23.34% |
Max Drawdown (1Y)Largest decline over 1 year | -49.22% | -27.41% | -21.81% |
Current DrawdownCurrent decline from peak | -38.75% | -11.18% | -27.57% |
Average DrawdownAverage peak-to-trough decline | -60.58% | -25.77% | -34.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.27% | 8.88% | +18.39% |
Volatility
ARTV vs. CGON - Volatility Comparison
Artiva Biotherapeutics, Inc (ARTV) has a higher volatility of 27.37% compared to CG Oncology, Inc (CGON) at 16.34%. This indicates that ARTV's price experiences larger fluctuations and is considered to be riskier than CGON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARTV | CGON | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.37% | 16.34% | +11.03% |
Volatility (6M)Calculated over the trailing 6-month period | 76.49% | 42.03% | +34.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 187.99% | 57.56% | +130.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 159.11% | 66.48% | +92.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 159.11% | 66.48% | +92.63% |
Dividends
ARTV vs. CGON - Dividend Comparison
Neither ARTV nor CGON has paid dividends to shareholders.
Financials
ARTV vs. CGON - Financials Comparison
This section allows you to compare key financial metrics between Artiva Biotherapeutics, Inc and CG Oncology, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ARTV and CGON have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARTV has higher volatility (27.37%) compared to CGON (16.34%). In terms of maximum drawdown, ARTV dropped -90.81% vs CGON's -67.47%.
CGON currently has the higher Sharpe Ratio (2.73 vs 2.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARTV and CGON
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer